Dashboard
1
Poor Management Efficiency with a low ROCE of 9.65%
- The company has been able to generate a Return on Capital Employed (avg) of 9.65% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -1.11% and Operating profit at -182.73% over the last 5 years
3
The company has declared Negative results for the last 10 consecutive quarters
4
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.15%
0%
-8.15%
6 Months
-4.2%
0%
-4.2%
1 Year
-9.74%
0%
-9.74%
2 Years
-26.83%
0%
-26.83%
3 Years
-57.23%
0%
-57.23%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shanghai Universal Biotech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.11%
EBIT Growth (5y)
-182.73%
EBIT to Interest (avg)
25.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.66
Sales to Capital Employed (avg)
0.55
Tax Ratio
90.91%
Dividend Payout Ratio
194.92%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.65%
ROE (avg)
2.44%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.61
EV to EBIT
0.34
EV to EBITDA
0.74
EV to Capital Employed
-0.03
EV to Sales
-0.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
287.10
279.70
2.65%
Operating Profit (PBDIT) excl Other Income
-5.00
0.30
-1,766.67%
Interest
0.00
0.00
Exceptional Items
2.80
3.40
-17.65%
Consolidate Net Profit
-7.20
9.90
-172.73%
Operating Profit Margin (Excl OI)
-39.50%
-13.10%
-2.64%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 2.65% vs -6.83% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -172.73% vs -40.36% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,112.80
1,222.70
-8.99%
Operating Profit (PBDIT) excl Other Income
-12.30
15.20
-180.92%
Interest
1.30
2.50
-48.00%
Exceptional Items
13.60
15.00
-9.33%
Consolidate Net Profit
10.10
40.30
-74.94%
Operating Profit Margin (Excl OI)
-34.30%
-5.30%
-2.90%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -8.99% vs 2.51% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -74.94% vs -62.20% in Dec 2023
About Shanghai Universal Biotech Co., Ltd. 
Shanghai Universal Biotech Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






